Search Results - "ULDRICK, T"

No evidence of ongoing HIV replication or compartmentalization in tissues during combination antiretroviral therapy: Implications for HIV eradication by Bozzi, G, Simonetti, F R, Watters, S A, Anderson, E M, Gouzoulis, M, Kearney, M F, Rote, P, Lange, C, Shao, W, Gorelick, R, Fullmer, B, Kumar, S, Wank, S, Hewitt, S, Kleiner, D E, Hattori, J, Bale, M J, Hill, S, Bell, J, Rehm, C, Grossman, Z, Yarchoan, R, Uldrick, T, Maldarelli, F

“…HIV persistence during combination antiretroviral therapy (cART) is the principal obstacle to cure. Mechanisms responsible for persistence remain uncertain;…”
Get full text

A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi’s sarcoma-associated herpesvirus vFLIP oncoprotein by Sakakibara, S, Espigol-Frigole, G, Gasperini, P, Uldrick, T S, Yarchoan, R, Tosato, G

“…Kaposi’s sarcoma-associated herpesvirus (KSHV) K13/vFLIP (viral Flice-inhibitory protein) induces transcription of numerous genes through NF-κB activation,…”
Get full text

Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE by HIRANO, M, MARTI, R, SCHWARTZ, J, HAWKS, R. G, MARTONE, D. L, CAIRO, M. S, DIMAURO, S, STANZANI, M, GARVIN, J. H, SAVAGE, D. G, CASALI, C, TADESSE, S, ULDRICK, T, FINE, B, ESCOLAR, D. M, VALENTINE, M. L, NISHINO, I, HESDORFFER, C

“…Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a multisystemic autosomal recessive disease due to primary thymidine phosphorylase (TP)…”
Get full text

In vivo analysis of HIV from an occupational exposure to laboratory adapted HIV-IIIB with 20-year follow-up: implications for reservoir formation by C. Lange, N. Lindo, R. Little, T. Uldrick, S. Hill, J. Bell, K. Lurain, R. Ramaswami, R. Yarchoan, F. Maldarelli

Get full text

An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa by Mosam, A, Uldrick, T S, Shaik, F, Carrara, H, Aboobaker, J, Coovadia, H

“…Roll-out of combination antiretroviral therapy (cART) in South Africa should impact on AIDS-associated Kaposi's sarcoma (KS). Government provision began in…”
Get more information

Clones of HIV-infected cells are widely distributed in T cell subsets in blood and in anatomic tissues by F. Maldarelli, M. Gozoulis, X. Wu, L. Perez, R. Gorelick, C. Lange, S. Hill, J. Virga, T. Uldrick, R. Yarchoan, S. Hughes

Get full text

Increasing incidence of Kaposi's sarcoma in black South Africans in KwaZulu-Natal, South Africa (1983-2006) by Mosam, A, Carrara, H, Shaik, F, Uldrick, T, Berkman, A, Aboobaker, J, Coovadia, H M

“…The aim of the study was to describe the temporal trends in the incidence of Kaposi's sarcoma (KS) in black South Africans in KwaZulu-Natal (KZN). The study…”
Get more information

IMMUNE AND VIRUS‐SPECIFIC RESPONSES IN PARTICIPANTS WITH PRIMARY EFFUSION LYMPHOMA RECEIVING LENALIDOMIDE, DOSE‐ADJUSTED EPOCH, AND RITUXIMAB (EPOCH‐R 2 ) by Lurain, K, Roshan, R, Ramaswami, R, Mangusan, R, Widell, A, Ekwede, I, Ziegelbauer, J. M, Uldrick, T. S, Whitby, D, Yarchoan, R, Krug, L. T

Get full text

35 Therapy with the immunomodulatory agent pomalidomide does not lead to changes in HIV-1 viral populations in vivo by S.A. Watters, M.N. Polizzotto, W. Shao, R. Gorelick, E.M. Anderson, I. Sereti, K. Aleman, L. Kouyoudjian, J.B. Zeldis, T. Uldrick, R. Yarchoan, F. Maldarelli

Get full text

OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy by G. Bozzi, S. Watters, F.R. Simonetti, E. Anderson, R. Gorelick, W. Shao, J. Bell, C. Rehm, R. Dewar, R. Yarchoan, T. Uldrick, F. Maldarelli

Get full text

HAART and response to therapy improve quality of life (QOL) of African patients with advanced HIV-associated Kaposi’s sarcoma (HIV-KS): a prospective analysis of QOL in the KAART trial by Mosam, Anisa, Shaik, F, Uldrick, T, Esterhuizen, T, Friedland, G, Scadden, D, Aboobaker, J, Coovadia, H

“…From: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA 26-27 April, 2010 Author…”
Get full text

41P Phase I analysis of ubamatamab (MUC16xCD3 bispecific antibody) in patients with recurrent ovarian cancer by Moore, K.N., O'Malley, D., Van Nieuwenhuysen, E., Hamilton, E., O'Cearbhaill, R.E., Yeku, O., Bouberhan, S., Hou, J.Y., Peterman, M., Goncalves, P., Schmidt, T., Yoo, S-Y., Zhu, M., Lowy, I., Rowlands, T., Uldrick, T., Miller, E.A., Liu, J.

Get full text

197TiP First-in-human (FIH) phase I/II study of ubamatamab, a MUC16xCD3 bispecific antibody, administered alone or in combination with cemiplimab in patients with recurrent ovarian cancer (OC) by Moore, K.N., Bouberhan, S., Hamilton, E., Liu, J., O'Cearbhaill, R.E., O'Malley, D., Papadimitriou, K., Schröder, D., Van Nieuwenhuysen, E., Yoo, S-Y., Peterman, M., Goncalves, P., Schmidt, T., Zhu, M., Lowy, I., Uldrick, T., Miller, E.A.

Get full text

A20/TNFAIP3 inhibits NF-[kappa]B activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein by Sakakibara, S, Espigol-frigole, G, Gasperini, P, Uldrick, T S, Yarchoan, R, Tosato, G

“…Kaposi's sarcoma-associated herpesvirus (KSHV) K13/vFLIP (viral Flice-inhibitory protein) induces transcription of numerous genes through NF-κB activation,…”
Get full text

A phase I dose-escalation study of azacitidine in combination with temozolomide in patients with soft tissue sarcomas by Matushansky, I., Coakley, K. E., Uldrick, T. S., Taub, R. N.

“…Abstract only…”
Get full text

Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma by Kranick, Sarah M, Goncalves, Priscila H, Stetler-Stevenson, Maryalice, Aleman, Karen, Polizzotto, Mark N, Little, Richard F, Yarchoan, Robert, Uldrick, Thomas S

Get full text

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa by Mosam, A, Shaik, F, Uldrick, TS, Friedland, GH, Scadden, DT, Aboobaker, J, Coovadia, HM

“…From: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA 26-27 April, 2010 Author details…”
Get full text

Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006) by Uldrick, TS, Mosam, A, Carrara, H, Shaik, F, Berkman, A, Coovadia, HM

Get full text

Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770 by Uldrick, TS, Mosam, A, Shaik, F, Friedland, G, Skadden, D, Jordaan, JP, Aboobaker, J, Coovadia, HM

Get full text

COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies by Goldman, Jason D, Robinson, Philip C, Uldrick, Thomas S, Ljungman, Per

“…SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly variable disease severity and a bimodal course characterized by acute…”
Get full text